(PharmaNewsWire.Com, May 18, 2021 ) The hemostasis valves market is expected to reach USD 175 million by 2023 from USD 132 million in 2018, at a CAGR of 5.8%. The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the hemostasis valves market; a favorable market scenario in these countries will serve to attract a number of players to focus on opportunities there.
The hemostasis valve Y-connectors segment is expected to account for the largest market share in 2018.
On the basis of type, the hemostasis valves market is segmented into hemostasis valve Y-connectors, double Y-connector hemostasis valves, one-handed hemostasis valves, and other hemostasis valves. In 2018, the hemostasis valve Y-connectors segment is expected to account for the largest share of the hemostasis valves market. The increasing number of interventional procedures worldwide is a key factor driving the growth of this segment.
Angiography to dominate the hemostasis valves market during the forecast period.
On the basis of application, the hemostasis valves market is segmented into angiography and angioplasty. The angiography segment is expected to account for the larger market share in 2018. The large share of this segment is attributed to the increasing number of angiography procedures performed worldwide.
North America is estimated to command the largest share of the market in 2018.
The hemostasis valves market is segmented into four major geographic segments North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America is expected to command the largest share of the global hemostasis valves market, followed by Europe. The large share of the North American market is attributed to increasing number of interventional surgeries and rising geriatric population.
The major players in the hemostasis valves market are Boston Scientific (US), Abbott (US), Teleflex Incorporated (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Argon Medical (US), Freudenberg Medical (US), and Scitech (Brazil).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
